BIOVENTUS INC - A (BVS) Fundamental Analysis & Valuation

NASDAQ:BVS • US09075A1088

8.96 USD
-0.14 (-1.54%)
Last: Mar 6, 2026, 11:44 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

BVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BVS while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.


Dividend Valuation Growth Profitability Health

4

1. BVS Profitability Analysis

1.1 Basic Checks

  • BVS had positive earnings in the past year.
  • In the past year BVS had a positive cash flow from operations.
  • BVS had negative earnings in 4 of the past 5 years.
  • In multiple years BVS reported negative operating cash flow during the last 5 years.
BVS Yearly Net Income VS EBIT VS OCF VS FCFBVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • BVS's Return On Assets of 1.11% is fine compared to the rest of the industry. BVS outperforms 73.91% of its industry peers.
  • With a decent Return On Equity value of 4.71%, BVS is doing good in the industry, outperforming 77.17% of the companies in the same industry.
  • BVS has a Return On Invested Capital of 6.62%. This is amongst the best in the industry. BVS outperforms 80.43% of its industry peers.
Industry RankSector Rank
ROA 1.11%
ROE 4.71%
ROIC 6.62%
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
BVS Yearly ROA, ROE, ROICBVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of BVS (1.39%) is better than 73.37% of its industry peers.
  • BVS has a Operating Margin of 8.03%. This is in the better half of the industry: BVS outperforms 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of BVS has declined.
  • Looking at the Gross Margin, with a value of 67.76%, BVS is in the better half of the industry, outperforming 73.37% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BVS has declined.
Industry RankSector Rank
OM 8.03%
PM (TTM) 1.39%
GM 67.76%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
BVS Yearly Profit, Operating, Gross MarginsBVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BVS Health Analysis

2.1 Basic Checks

  • BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for BVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BVS Yearly Shares OutstandingBVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BVS Yearly Total Debt VS Total AssetsBVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • BVS has an Altman-Z score of 1.37. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
  • BVS's Altman-Z score of 1.37 is in line compared to the rest of the industry. BVS outperforms 54.35% of its industry peers.
  • BVS has a debt to FCF ratio of 6.22. This is a slightly negative value and a sign of low solvency as BVS would need 6.22 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.22, BVS is in the better half of the industry, outperforming 76.63% of the companies in the same industry.
  • A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
  • BVS has a worse Debt to Equity ratio (1.93) than 81.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 6.22
Altman-Z 1.37
ROIC/WACC0.6
WACC10.96%
BVS Yearly LT Debt VS Equity VS FCFBVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.74 indicates that BVS should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.74, BVS is doing worse than 67.93% of the companies in the same industry.
  • A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
  • BVS's Quick ratio of 1.14 is on the low side compared to the rest of the industry. BVS is outperformed by 71.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.14
BVS Yearly Current Assets VS Current LiabilitesBVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BVS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.68% over the past year.
  • Measured over the past years, BVS shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.98% on average per year.
EPS 1Y (TTM)44.68%
EPS 3Y61.98%
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.77%

3.2 Future

  • BVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.25% yearly.
  • The Revenue is expected to grow by 6.77% on average over the next years.
EPS Next Y14.86%
EPS Next 2Y14.11%
EPS Next 3YN/A
EPS Next 5Y12.25%
Revenue Next Year6.78%
Revenue Next 2Y6.62%
Revenue Next 3YN/A
Revenue Next 5Y6.77%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BVS Yearly Revenue VS EstimatesBVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 200M 400M 600M
BVS Yearly EPS VS EstimatesBVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. BVS Valuation Analysis

4.1 Price/Earnings Ratio

  • BVS is valuated correctly with a Price/Earnings ratio of 13.18.
  • BVS's Price/Earnings ratio is rather cheap when compared to the industry. BVS is cheaper than 89.13% of the companies in the same industry.
  • BVS is valuated cheaply when we compare the Price/Earnings ratio to 26.69, which is the current average of the S&P500 Index.
  • BVS is valuated reasonably with a Price/Forward Earnings ratio of 11.47.
  • Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 92.39% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BVS to the average of the S&P500 Index (24.79), we can say BVS is valued rather cheaply.
Industry RankSector Rank
PE 13.18
Fwd PE 11.47
BVS Price Earnings VS Forward Price EarningsBVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaply inside the industry as 89.13% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 96.20% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.87
EV/EBITDA 11.22
BVS Per share dataBVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BVS's earnings are expected to grow with 14.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BVS Dividend Analysis

5.1 Amount

  • BVS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BVS Fundamentals: All Metrics, Ratios and Statistics

BIOVENTUS INC - A

NASDAQ:BVS (3/6/2026, 11:44:01 AM)

8.96

-0.14 (-1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-05
Earnings (Next)N/A
Inst Owners74.45%
Inst Owner Change2.28%
Ins Owners2.5%
Ins Owner Change0.55%
Market Cap741.53M
Revenue(TTM)N/A
Net Income(TTM)7.82M
Analysts82.5
Price Target14.79 (65.07%)
Short Float %2.63%
Short Ratio6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)-3.33%
PT rev (3m)-3.33%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 13.18
Fwd PE 11.47
P/S 1.32
P/FCF 13.87
P/OCF 13.24
P/B 4.46
P/tB N/A
EV/EBITDA 11.22
EPS(TTM)0.68
EY7.59%
EPS(NY)0.78
Fwd EY8.72%
FCF(TTM)0.65
FCFY7.21%
OCF(TTM)0.68
OCFY7.56%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.89
PEG (5Y)N/A
Graham Number5.54
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 4.71%
ROCE 8.38%
ROIC 6.62%
ROICexc 7.18%
ROICexgc 31.69%
OM 8.03%
PM (TTM) 1.39%
GM 67.76%
FCFM 9.48%
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 6.22
Debt/EBITDA 3.44
Cap/Depr 5.36%
Cap/Sales 0.45%
Interest Coverage 250
Cash Conversion 60.26%
Profit Quality 683.69%
Current Ratio 1.74
Quick Ratio 1.14
Altman-Z 1.37
F-Score8
WACC10.96%
ROIC/WACC0.6
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.68%
EPS 3Y61.98%
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y14.86%
EPS Next 2Y14.11%
EPS Next 3YN/A
EPS Next 5Y12.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.77%
Revenue Next Year6.78%
Revenue Next 2Y6.62%
Revenue Next 3YN/A
Revenue Next 5Y6.77%
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.93%
EBIT Next 3Y11.97%
EBIT Next 5Y10.4%
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%

BIOVENTUS INC - A / BVS FAQ

Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to BVS.


What is the valuation status for BVS stock?

ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.


Can you provide the profitability details for BIOVENTUS INC - A?

BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.


What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 13.18 and the Price/Book (PB) ratio is 4.46.


What is the financial health of BIOVENTUS INC - A (BVS) stock?

The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.